Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
or

Dova Pharmaceuticals Inc (DOVA)

Dova Pharmaceuticals Inc (DOVA)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
28.04 +0.04 (+0.14%) 11/11/19 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 28.04 unch (unch) -
Quote Overview for Mon, Nov 11th, 2019
Day Low
28.01
Day High
28.19
Open 28.02
Previous Close 28.00 28.00
Volume 1,488,000 1,488,000
Avg Vol 499,265 499,265
Stochastic %K 12.57% 12.57%
Weighted Alpha +106.70 +106.70
5-Day Change -0.02 (-0.07%) -0.02 (-0.07%)
52-Week Range 5.62 - 28.54 5.62 - 28.54
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 807,608
  • Shares Outstanding, K 28,802
  • Annual Sales, $ 10,360 K
  • Annual Income, $ -72,280 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 2.74
  • Price/Sales 77.88
  • Price/Cash Flow N/A
  • Price/Book 15.58
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.56
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/14/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate -0.64
  • Number of Estimates 3
  • High Estimate -0.61
  • Low Estimate -0.66
  • Prior Year -0.69
  • Growth Rate Est. (year over year) +7.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
27.93 +0.39%
on 11/07/19
Period Open: 28.40
28.54 -1.75%
on 10/31/19
-0.36 (-1.27%)
since 10/11/19
3-Month
14.18 +97.74%
on 08/26/19
Period Open: 16.01
28.54 -1.75%
on 10/31/19
+12.03 (+75.14%)
since 08/09/19
52-Week
5.62 +398.93%
on 12/20/18
Period Open: 16.89
28.54 -1.75%
on 10/31/19
+11.15 (+66.02%)
since 11/09/18

Most Recent Stories

More News
Istari Oncology Hires Marc Banjak as General Counsel and Secretary as the Company Prepares for a Critical Period of Development and Expansion

Istari Oncology, Inc. , a clinical-stage biotechnology company today announced that Marc Banjak has joined the company as general counsel and secretary. Mr. Banjak comes to Istari from Dova Pharmaceuticals...

DOVA : 28.04 (+0.14%)

Business Summary

Dova Pharmaceuticals, Inc. is a pharmaceutical company. It focuses on acquiring, developing and commercializing drug candidates for thrombocytopenia diseases. The company's drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist which are in clinical stage. Dova Pharmaceuticals,...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 28.27
1st Resistance Point 28.15
Last Price 28.04
1st Support Level 27.96
2nd Support Level 27.89
3rd Support Level N/A

See More

52-Week High 28.54
Last Price 28.04
Fibonacci 61.8% 19.78
Fibonacci 50% 17.08
Fibonacci 38.2% 14.38
52-Week Low 5.62

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro